<DOC>
	<DOCNO>NCT01863615</DOCNO>
	<brief_summary>The objective study confirm two formulation isotretionin ( capsule ) bioequivalent . Test product Oratane® 20 mg ( Laboratorios Dermatológicos Darier ) reference product Roaccutan® 20 mg ( Productos Roche ) . Two capsule administer together single dosage . The study prospective , open-label , randomize , crossover , single dose , 02 treatment , 02 sequence 02 period , fed condition . The population compose 36 healthy volunteer , male adult 18-45 year . The comparative bioavailability two formulation evaluate base statistical comparison relevant pharmacokinetic parameter , obtain data drug concentration blood .</brief_summary>
	<brief_title>Bioequivalence Study Isotretinoin</brief_title>
	<detailed_description />
	<mesh_term>Skin Diseases , Infectious</mesh_term>
	<mesh_term>Isotretinoin</mesh_term>
	<criteria>Male volunteer . Ages 18 45 year old . BMI ( Body Mass Index ) 20 26 kg/m2 . Antidoping test negative result . Clinical biochemical test value : Hematic Biometry , Urine Analysis , Biochemical Profile : ( Glucose , Ureic Nitrogen , Urea , Creatinine , Uric Acid , Cholesterol , Triglycerides , Total Proteins , Albumin , Globulin , Bilirubin ( total , indirect direct ) , Alkaline Phosphatase , Lactic Dehydrogenase , AST , ALT , Calcium , Phosphorus , Sodium , Potassium , Chlorine Iron ) , Ac VIH , AgsHB RPR ( luetic test ) , must fall within interval minimum maximum value connection say test accept value . Normal Electrocardiogram Chest Xrays . In exception case , accept may candidate previously mention test exceed regard consider valid maximum minimum accept normal value , long involves isolate value manifestation could allow assume give value relate disease remnant another . These case must approve clinical area declare `` Nonclinically significant '' . Electrocardiographic Anomalies ; radiological Antidoping test positive result , Positive result regard RPR ; VIH AgsHB test . Personal family history allergy medication question . Having kind allergy , since person high risk suffer medicamentous allergy . Tobacco use . Recreational drug use . Persons undergo medical treatment . Existence concurrent intercurrent disease . Existence justify doubt regard questionnaire answer truthfulness . Having participate bioequivalence bioavailability study donate blood 2 month study . Presence clinically important gastrointestinal disease malabsorption history last year . Presence medical condition require regular medication ( prescription overthe counter medication ) systemic absorption . Narcotics alcohol addiction history require treatment . Finally , exclude volunteer meet establish Mexican Official Standard NOM177SSA11998 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>pharmacokinetics</keyword>
	<keyword>Isotretinoin</keyword>
	<keyword>bioequivalence</keyword>
	<keyword>Mexico</keyword>
</DOC>